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Background
Cardiac complications are the main cause of death in
thalassemia major (TM) patients. Cardiovascular Magnetic
Resonance (CMR) plays a key role in their management,
assessing myocardial iron overload (MIO), biventricular
function, atrial dimensions, and myocardial fibrosis. We
evaluated the predictive value of CMR parameters for
heart failure and arrhythmias.
Methods
We followed prospectively 487 TM patients free of a cardiac
complications at the first CMR. All prognostic variables
associated with the outcome at the univariate Cox model
were placed in the multivariate model and were ruled
out if they did not significantly improve the adjustment.
Results
At baseline the mean age was 29.5 ± 9.0 years and 222
patients were males. The mean follow-up time was 58 ±
18 months. After the first CMR only the 37.8% of the
patients did not change the chelation regimen or the
frequency/dosage. We recorded 19 episodes of heart
failure. Male sex, heart iron, ventricular dysfunction,
ventricular dilation, atrial dilation, and myocardial fibro-
sis were significant univariate prognosticators. In the
multivariate analysis the independent predictive factors
were an homogeneous pattern of MIO (compared to no
MIO) (HR = 5.81, 95%CI = 1.42-23.74, P = 0.014), myocar-
dial fibrosis (HR = 4.93, 95%CI = 1.71-14.71, P = 0.003)
and ventricular dysfunction (HR = 3.45, 95%CI = 1.19-9.98,
P = 0.022). Figure 1 shows the Kaplan-Meier survival
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curves for the prognosticators. Arrhythmias (all supraven-
ticular hyperhyperkinetic) occurred in 19 patients. Male
sex, atrial dilatation and ventricular dysfunction were
significant univariate prognosticators. In the multivariate
analysis the independent predictive factors were male sex
(HR = 3.17, 95%CI = 1.02-9.87, P = 0.047) and atrial dila-
tion (HR = 3.07, 95%CI = 1.14-8.23, P = 0.026). Figure 2
shows the Kaplan-Meier survival curves for the prognosti-
cators. Serum ferritin and liver iron were not predictive
factors for heart failure or arrhythmias.
Conclusions
We detected few cardiac events thanks to a MR-guided,
patient-specific adjustment of the chelation therapy.
Severe and homogeneous MIO, myocardial fibrosis and
ventricular dysfunction identify patients at high risk of
heart failure. Heart T2* doesn’t have any power in pre-
dicting arrhythmias while male sex and atrial dilation
are independent prognosticators.
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